GLAXOSMITHKLINE PLC - SPONSORED ADR (GSKXXXX)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q1 2024
1.28 M
Holdings value Q1 2024
$54.9 M
Value change Q1 2024
+$448 K
Grand Portfolio weight change Q1 2024
+0%
Number of holders
9
Number of buys Q1 2024
1
Number of sells Q1 2024
-1
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
37733W105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 1.28 M $54.9 M +$448 K $42.87 9
2023 Q4 1.27 M $47.1 M -$923 K $37.06 8
2023 Q3 1.3 M $47 M +$725 K $36.25 9
2023 Q2 1.28 M $45.5 M -$504 K $35.64 8
2023 Q1 1.29 M $45.9 M +$865 K $35.58 9
2022 Q4 1.27 M $44.5 M -$39.6 M $35.14 12
2022 Q3 2.57 M $75.8 M -$13.5 B $29.43 29
2022 Q2 314 M $13.7 B -$336 M $43.53 801
2022 Q1 326 M $14.2 B +$163 M $43.56 895
2021 Q4 305 M $13.4 B +$198 M $44.10 886
2021 Q3 317 M $12.1 B +$152 M $38.21 763
2021 Q2 313 M $12.5 B -$352 M $39.82 775
2021 Q1 316 M $11.3 B +$543 M $35.69 751
2020 Q4 282 M $10.4 B +$200 M $36.80 786
2020 Q3 297 M $11.2 B -$400 M $37.64 804
2020 Q2 305 M $12.4 B -$289 M $40.79 817
2020 Q1 311 M $11.8 B +$916 M $37.89 787
2019 Q4 287 M $13.5 B +$320 M $46.99 869
2019 Q3 281 M $12 B +$122 M $42.68 789
2019 Q2 278 M $11.1 B -$13 M $40.02 782
2019 Q1 280 M $11.7 B +$201 M $41.79 825
2018 Q4 273 M $10.4 B +$78.2 M $38.21 777
2018 Q3 272 M $10.9 B +$211 M $40.17 777
2018 Q2 247 M $9.94 B -$271 M $40.31 776
2018 Q1 275 M $10.8 B +$122 M $39.07 771
2017 Q4 272 M $9.66 B +$1.02 B $35.47 751
2017 Q3 242 M $9.83 B +$527 M $40.60 737
2017 Q2 229 M $9.88 B +$324 M $43.12 771
2017 Q1 221 M $9.31 B +$255 M $42.16 777
2016 Q4 208 M $8.02 B +$51.4 M $38.51 751
2016 Q3 205 M $8.86 B -$126 M $43.13 728
2016 Q2 209 M $9.07 B +$231 M $43.34 731
2016 Q1 205 M $8.33 B -$334 M $40.55 708
2015 Q4 215 M $8.66 B -$154 M $40.35 707
2015 Q3 216 M $8.31 B -$453 M $38.45 691
2015 Q2 230 M $9.57 B -$824 M $41.65 708
2015 Q1 250 M $11.5 B -$101 M $46.15 727
2014 Q4 253 M $10.8 B -$557 M $42.74 708
2014 Q3 265 M $12.2 B -$647 M $45.97 693
2014 Q2 278 M $14.9 B +$861 M $53.48 709
2014 Q1 262 M $14 B -$161 M $53.43 699